Target Malaria is a not-for-profit research consortium that aims to develop and share new, cost-effective and sustainable genetic technologies to modify mosquitoes and reduce malaria transmission. Our vision is to contribute to a world free of malaria. We aim to achieve excellence in all areas of our work, creating a path for responsible research and development of genetic technologies, such as gene drive.
| Website | https://targetmalaria.org/ |
| Revenue | $5.9 million |
| Employees | 71 (47 on RocketReach) |
| Founded | 2012 |
| Industry | Research Services, Business Services General, Business Services |
| Keywords | Malaria Prevention, Malaria Eradication, Mosquito Control, Disease Vector Control, Genetic Engineering, Vector Borne Disease, Gene Editing, Public Health, Global Health, Disease Control, Insect Control, Innovation In Health, Biotechnology Research, Scientific Research, Sustainable Solutions, Nonprofit Research, Health Technology |
| Competitors | Bayer, Syngenta, Moderna Therapeutics, CureVac, Factorial Energy, Zymergen, Inc., Oxitec, AgBiome, MosquitoMate, Genetic Technologies, Inc. +31 more (view full list) |
| SIC | SIC Code 73 Companies, SIC Code 738 Companies |
| NAICS | NAICS Code 56 Companies, NAICS Code 561 Companies |
Looking for a particular Target Malaria employee's phone or email?
The Target Malaria annual revenue was $5.9 million in 2026.
Naima Sykes is the Director of Global Stakeholder Engagement of Target Malaria.
47 people are employed at Target Malaria.
The NAICS codes for Target Malaria are [56, 561].
The SIC codes for Target Malaria are [73, 738].